AUGUST 2018
Measured by Google Analytics
FEATURED COMPANIES
Y-mAbs Therapeutics Looks at an $80 Million IPO
Alex Keown
22 Sep 2018
BIOSPACE
1
EU approves fifth copy of AbbVie`s $18 billion drug Humira
Ben Hirschler
21 Sep 2018
REUTERS
2
Pfizer’s Prevnar-13 successor takes aim at Merck rival
Phil Taylor
21 Sep 2018
PM LIVE
3
GlaxoSmithKline fails to warn of pandemic flu vaccine’s alarming safety signal
Angus Liu
21 Sep 2018
FIERCE PHARMA
4
FDA chief says he`s more worried about teens using marijuana than e-cigarettes
Angelica LaVito
21 Sep 2018
CNBC
5
Novartis` Alcon adds online training portal to supplement eyecare centers
Beth Bulik
21 Sep 2018
FIERCE PHARMA
6
Celgene Walks Away from Licensing Deal with Beleaguered OncoMed
Alex Keown
21 Sep 2018
BIOSPACE
7
Rubius Therapeutics kicks off $155M renovation of former Alexion plant
Joseph Keenan
21 Sep 2018
FIERCE PHARMA
8
China`s Hillhouse Capital`s New Fund Has $10.6 Billion to Invest
Mark Terry
21 Sep 2018
BIOSPACE
9
FDA delays approval of GC Pharma’s IVIG-SN again
Sohn Ji-young
21 Sep 2018
KOREA HERALD
10
MARKET PLACE
Dexmedetomidine API needed in Bulgaria
22 Sep 2018
Centella Asiatica API needed in Turkey
22 Sep 2018
EP grade Nystatin API needed in India
22 Sep 2018
Hyaluronidase API (1kg) needed in Korea
22 Sep 2018
Various Intermediates needed in China
21 Sep 2018
Famotidine API (10kg) needed in United States
21 Sep 2018
Bepotastine (1.5%) eye drop needed in India
20 Sep 2018
BLOG & ANALYSIS
This week, Phispers brings you the latest on the valsartan contamination. FDA and EMA have found the...
In August, the biotech boom of 2018 continued unabated and the Wall Street Journal reported that in...
This week, Phispers has news on Indian generic drug makers. First, Sun Pharma and Dr. Reddy’s ...
